Article
Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma.
Medical oncology (Northwood, London, England) - 31 Jan 2018
Motono Nozomu, Funasaki Aika, Sekimura Atsushi, Usuda Katsuo, Uramoto Hidetaka
Abstract excerpt
The epidermal growth factor receptor (EGFR) mutation status has become one of the most important factors in the treatment of non-small cell lung cancer. However, the relationship between EGFR mutation and the histologic subtype of lung adenocarcinoma remains to be fully elucidated. We examined the relationship between the predominant subtype of adenocarcinoma and the prognosis and investigated the correlation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
